[1] |
WANG Yaya, CHU Zixuan, YANG Junling, Olajide E. Olaleye, HE Rongrong, LI Muzi, CHENG Chen, LI Chuan.
Potential health benefits of resveratrol: a pharmacokinetics-caused conundrum
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 931-954.
|
[2] |
WANG Yeqing, WANG Yuhong, LIU Jian, ZHAO Hongqing, ZOU Manshu.
Research progress of relevance between cholecystokinin and depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 672-679.
|
[3] |
DENG Li, TIAN Jing.
Resveratrol suppresses NLRP3 inflammasome activation in colonic epithelial cells triggered by Escherichia coli O104∶H4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 167-173.
|
[4] |
WU Yi, ZHU Akao, SHAN Yuqiang, YING Rongchao, JIN Huicheng.
Resveratrol regulates miR-409-3p/FKBP14 to inhibit the malignant biological processes of gastric cancer BGC823 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 968-975.
|
[5] |
YUAN Lijialong, YUAN Ronghui, WANG Jin, DENG Ziwei, WANG Hongqiang, DENG Ye, GONG Lu, JIN Yuanxiang, SHI Zhihua.
Effects of resveratrol on autophagy of tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1066-1073.
|
[6] |
JIANG Weiyu, HU Xudong, CHEN Yunlin, RUAN Chaoyue, XU Nanjian, WANG Yang, XU Dingli, ZHANG Jiaming, LI Haojie, MA Weihu.
Esveratrol inhibits NLRP3 inflammasome activation in rabbits with spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 850-856.
|
[7] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[8] |
ZHOU Haiyan, WANG Kailing .
Resveratrol protects human retinal pigment epithelial cells from toxicity of high glucose by up-regulation of miR-26a
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 285-292.
|
[9] |
PAN Yalan, YUAN Wenchao, MA Yong, GUO Yang, ZHENG Suyang, XU Guihua, LIU Jiahuan.
Effect of JiSuiKang on the microglia infiltration and neuron survival in the spinal cord injury area of rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 151-158.
|
[10] |
SONG Hui, WANG Yinghao.
Resveratrol inhibits the proliferation of retinoblastoma cells via miR-937/FOXQ1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 174-181.
|
[11] |
XU Wei, QU Weimin, HONG Zongyuan.
Advances in research on the mechanism of general anesthesia by specific manipulation of neuron activities
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 825-829.
|
[12] |
ZHANG Rui, LI Bingjie, LI Qinglin.
Jujuboside A attenuates LPS-induced microglial activation and provides neuroprotection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 126-131.
|
[13] |
ZHANG Jie, CHEN Zhiwu.
Effect and mechanism of total flavones of rhododendra on membrane hyperpolarization in rat hippocampal neurons and EA.hy926 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 606-610.
|
[14] |
LIU Jiangang, WANG Xiaobo.
Expression and significance of TRPV1 and TRPA1 in DRG neurons of rats with endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 617-621.
|
[15] |
YU Qinyun, SU Xiaogong, BAO Qiying, CHEN Xiaoyan.
Effect of resveratrol on the Wnt/β-Catenin pathway in ovariectomized osteoporosis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 645-649.
|